Browsing Tag
Massachusetts
113 posts
Is Parabilis Medicines’ $670m Nasdaq IPO a biotech comeback signal or a high-risk oncology wager?
Find out how Parabilis Medicines’ upsized Nasdaq IPO reshapes biotech financing, Regeneron validation and investor appetite for Helicon platform drugs now.
US offshore wind lawsuit turns Trump energy policy into a high-stakes federalism fight
Trump’s fossil fuel pivot now faces a state lawsuit. Offshore wind has become a test of federal power, clean energy planning and investor risk.
UnitedHealth (UNH) unit sued by Massachusetts over alleged $100m MassHealth upcoding scheme
Massachusetts is suing a UnitedHealth unit over an alleged $100M MassHealth upcoding scheme. UNH calls it meritless, but the precedent risk is the real story.
Iran War Powers vote fails 47 to 50 one day before May 1 statutory deadline expires
Senate rejected the sixth Iran War Powers Resolution 47 to 50 on April 30. The 60-day statutory deadline arrives Friday, with Trump's legal authority unresolved.
Why RTX Corporation’s $904.6m Army contract matters for U.S. air defense modernization
RTX Corporation’s Raytheon unit won a $904.6 million Army contract modification for LTAMDS radar production. Read what it means for growth and defense markets.
Two deals, $18.2m, and one big question: Is VMD Companies building Middleborough’s next industrial hub?
VMD Companies has closed its second major Canopy Drive land sale. Find out what the Indus deal means for Middleborough and industrial growth.
Millions at risk as deadly U.S. winter storm claims dozens of lives and another Arctic blast looms
At least 62 dead, millions without power, and another Arctic blast ahead—see how the deadly U.S. winter storm is unfolding and what’s coming next.
CPS Technologies Corporation (NASDAQ: CPSH) wins $15.5m contract with global semiconductor maker
See how CPS Technologies’ $15.5 million contract win positions the company for growth in power-module components and electrification infrastructure.
Charles River Laboratories appoints Michael G. Knell as interim CFO as Flavia Pease exits
Charles River Labs appoints Michael Knell interim CFO as Flavia Pease departs. Find out how this move impacts financial guidance and investor sentiment today.
Insulet names Flavia Pease as new CFO while signaling stronger Q3 revenue growth momentum
Insulet (NASDAQ: PODD) taps Flavia Pease as CFO and expects Q3 revenue growth to surpass guidance. Find out what this means for investors and the medtech sector.